Non-M3 acute myeloid leukemia

Clinical trials for Non-M3 acute myeloid leukemia explained in plain language.

Never miss a new study

Get alerted when new Non-M3 acute myeloid leukemia trials appear

Sign up with your email to follow new studies for Non-M3 acute myeloid leukemia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

The prognostic significance of C-Reactive protein to albumin ratio, albumin to fibrinogen ratio, and serum ferritin level in newly diagnosed de novo Non-M3 acute myeloid leukemia patients

Not yet recruiting

This prospective cohort study aims to evaluate the prognostic significance of the C-reactive protein-to-albumin ratio (CAR), albumin-to-fibrinogen ratio (AFR), and serum ferritin level in newly diagnosed de novo non-M3 acute myeloid leukemia patients at Assiut University Hospital…

Matched conditions: NON-M3 ACUTE MYELOID LEUKEMIA

Sponsor: Assiut University

Last updated Sep 09, 2026 16:00 UTC

Non-M3 acute myeloid leukemia

Get alerted when new Non-M3 acute myeloid leukemia trials appear

The prognostic significance of C-Reactive protein to albumin ratio, albumin to fibrinogen ratio, and serum ferritin level in newly diagnosed de novo Non-M3 acute myeloid leukemia patients